Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Investigative Report Calls J&J “America’s Most Admired Lawbreaker” September 28, 2015 Austin Kirk Add Your Comments In what is being referred to as a “docu-serial,” the Huffington Post has launched a 15-chapter, in-depth examination of the illegal sales practices of Johnson & Johnson, focusing on the pharmaceutical company’s promotion of the antipsychotic Risperdal to the elderly and children, despite reports of severe problems among those users. The series, titled “America’s Most Admired Lawbreaker”, is being released one chapter per day, and includes a blistering analysis, complete with court records and company memos, of how the Johnson & Johnson exposed children and the elderly to potential Risperdal side effects, such as breast growth among boys and an increased risk of death for dementia patients, in order to reach projected sales numbers. In a letter from the editors of the Huffington Post, they warn that the series is emotional and may change how consumers across the U.S. feel about the pharmaceutical industry and the drugs they consume. Learn More About Risperdal Lawsuits Side effects of Risperdal linked to risk of breast growth among young boys, or gynecomastia. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Risperdal Lawsuits Side effects of Risperdal linked to risk of breast growth among young boys, or gynecomastia. Learn More SEE IF YOU QUALIFY FOR COMPENSATION “At some point over the course of this massive, magisterial 15-chapter story, you will get angry, and you will stay angry,” the letter previewing the series warns. “It may happen when you learn that Johnson & Johnson handed out promotional Legos to pediatricians so that they’d be more likely to prescribe a drug called Risperdal to children with behavioral problems, although the FDA had repeatedly told the company not to market it to children. It may happen when you read that a team of scientists and company executives decided to massage the numbers on a study showing that Risperdal puts little boys at risk of developing large breasts…” Risperdal (risperidone) is a popular antipsychotic medication, which is widely used among children for treatment of schizophrenia, bipoloar disorder and irritability associated with autism. However, side effects of the medication have been linked to an increase in the amount of the hormone prolactin in the blood, which is a protein hormone that induces and maintains lactation in women after they give birth. For boys and young men using Risperdal, prior research has suggested that this may result in the development of enlarged breasts as part of a medical condition known as gynecomastia. Johnson & Johnson currently faces more than 1,300 Risperdal lawsuits over failure to adequately warn about the risk of breast growth for boys, alleging that the drug maker withheld known information about the risk of male breast growth from consumers and the medical community. According to evidence presented in the litigation, Johnson & Johnson has reportedly known about the link between Risperdal and gynecomastia since at least 2001, yet chose not to update warnings provided to parents about the male breast growth risks for years. Cases Uncovered Corporate Wrongdoing In addition to verdicts and Risperdal settlements for victims, the cases have led to the release of documents detailing just how far Johnson & Johnson went to flaunt the law. While under a prohibition by the FDA from promoting Risperdal for use by children, Johnson & Johnson’s own documents detail how the company went ahead and did just that, a procedure known as “off-label” marketing. Call report notes, linked to in the story, include sales representatives gloating over getting doctors to prescribe the drug to children. “Sold him on efficacy and safety in children,” one rep is quoted as saying. “Remind[ed] her that Risperdal is very effective and safe because she sees lots of children and adolescents,” another is quoted as saying in the company’s own call notes. Off-label marketing is illegal. While doctors can prescribe approved drugs for any reason they see fit, drug companies cannot promote or market them for uses that have not been established as safe and effective. Without the off-label marketing rules, which were put in place by the John F. Kennedy administration, drug companies could tell you cough syrup cured cancer, and you would have little means to find out otherwise. A number of pharmaceutical companies are pushing for the law to be overturned, claiming it violates their First Amendment rights. Eventually, Johnson & Johnson’s activities were exposed by a former sales representative, Judy Doetteri, who wore a recording device to marketing presentations that the federal government said established Johnson & Johnson was conspiring to market Risperdal for uses that were not approved by the FDA. Doetteri and several other employees filed whistleblower lawsuits that not only revealed the company’s illegal promotions to children, but also uncovered a kickback scheme with the nation’s number one provider of drugs to nursing homes, where Risperdal was used as a chemical restraint to control and sedate dementia patients, although the FDA warns that antipsychotics do not help elderly patients with dementia and increases their risk of dying. The Department of Justice (DOJ) began investigating Johnson & Johnson’s marketing of Risperdal in 2004, looking into an alleged kickback scheme between the drug maker and Omnicare, the nation’s largest provider of drugs to nursing homes. In 2009, Omnicare reached a settlement with DOJ over kickback charges. DOJ investigators indicated that Johnson & Johnson paid Omnicare millions to push off-label use of Risperdal to nursing home doctors and hid the kickbacks as data fees, education fees and payments to attend Omnicare meetings. In January 2010, the DOJ filed a civil False Claims Act complaint againstJohnson & Johnson, which also accused the drug maker of illegally promoting Risperdal for use among children prior to obtaining FDA approval for such use. The investigation resulted in a $2.2 billion agreement to settle the government’s Risperdal marketing claims in November 2013, including $485 million in criminal fines and forfeitures, as well as $1.72 billion in settlements split between the states and federal government. In the Huffington Post story, analysts note that the company’s legal costs are a cost of doing business, and the company’s more than $20 billion in revenue barely twitched at the federal and legal payouts. No one went to jail, and the head of Risperdal marketing at the time, Alex Gorsky, is now the current Johnson & Johnson chairman and chief executive. However, most of the lawsuits against the company remain unresolved, and could end up costing the company significantly more. In February 2015, the first Risperdal bellwether trial to go before a jury resulted in a $2.5 million jury award for Austin Pledger, a young man with autism who now has 46DD breasts and is a major subject of the Huffington Post investigation. A second case the following month ending with a defense verdict. However, while that second jury found that the plaintiff failed to establish that his abnormal breast growth was caused by the medication, the same jury determined that Johnson & Johnson failed to adequately warn the boys and their parents about the gynecomastia risks. A third bellwether case was settled out of court in May. Tags: Antipsychotics, Chemical Restraint, Childrens Drug, Dementia, Gynecomastia, Johnson & Johnson, Male Breast Growth, Nursing Home Abuse, Risperdal Image Credit: Image via <a href="http://www.shutterstock.com/gallery-762415p1.html?cr=00&pl=edit-00">Gil C</a> / <a href="http://www.shutterstock.com/editorial?cr=00&pl=edit-00">Shutterstock.com</a> More Risperdal Lawsuit Stories Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders December 14, 2022 Breast Cancer Side Effects Linked to Antipsychotic Medications: Study December 9, 2021 $70 Million Verdict in Risperdal Lawsuit Upheld After U.S. Supreme Court Declines To Review May 18, 2021 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: yesterday) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025) 12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (Posted: 2 days ago) A dozen hair dye lawsuits over bladder cancer risks have been consolidated under one California state judge for coordinated pretrial proceedings. MORE ABOUT: HAIR DYE LAWSUITJudge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025) BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (Posted: 3 days ago) Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended. MORE ABOUT: BIOZORB LAWSUITLawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)
Case Study Suggests Even Low-Dose Risperdal Side Effects May Cause Tardive Dyskinesia Movement Disorders December 14, 2022
$70 Million Verdict in Risperdal Lawsuit Upheld After U.S. Supreme Court Declines To Review May 18, 2021
Depo-Provera Wrongful Death Lawsuit Blames Injections for Fatal Brain Tumor (Posted: yesterday) A wrongful death lawsuit claims a woman’s sister died of a Depo-Provera brain tumor which was not discovered until after her death. MORE ABOUT: DEPO-PROVERA LAWSUITLawsuit Alleges Depo-Provera DMPA Injection Increases Brain Tumor Risks (06/20/2025)Ortho-Cept, Similar Birth Control Pills Linked to Intracranial Meningioma Risks, Study Warns (06/17/2025)Status of Depo-Provera Shot Lawsuits Outlined by MDL Judge (06/13/2025)
12 Hair Dye Lawsuits Over Bladder Cancer Risks Assigned to One Judge in California State Court (Posted: 2 days ago) A dozen hair dye lawsuits over bladder cancer risks have been consolidated under one California state judge for coordinated pretrial proceedings. MORE ABOUT: HAIR DYE LAWSUITJudge To Meet With Hair Dye Lawyers in Bladder Cancer Lawsuit for Initial Status Conference (06/16/2025)Lawsuit Claims Paul Mitchell, Redken, Other Hair Dyes Led to Bladder Cancer Diagnosis for Hairdresser (05/09/2025)Salon Stylist Files Lawsuit Over Bladder Cancer From Hair Dye Products (05/02/2025)
BioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (Posted: 3 days ago) Following a Class I recall, more than 100 BioZorb lawsuits have been filed by breast cancer survivors who suffered painful complications after the surgical tissue marker failed to dissolve as intended. MORE ABOUT: BIOZORB LAWSUITLawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (05/14/2025)